Abstract | BACKGROUND: METHODS: Direct sequencing of bisulfite-treated genomic DNA, conventional methylation-specific PCR (MSP), real-time quantitative methylation-specific PCR, immunohistochemistry, colony formation assay, and statistical analysis. RESULTS: We found that the melanoma cell adhesion molecule (MCAM) gene promoter was specifically methylated in prostate cancer cell lines and primary prostate cancer (PCa) but not in non-neoplastic prostate (BPH) tissues by direct sequencing of bisulfite-treated genomic DNA and conventional methylation-specific PCR (MSP). Further analysis with quantitative MSP showed greater hypermethylation of the MCAM promoter (80%, 70/88) in primary prostate cancer compared to 12.5% (3/24) in BPH. Prostatic intraepithelial neoplasias (PIN), potential precursors of prostate carcinoma, showed an intermediate methylation rate of 23% (7/30). We further observed that MCAM promoter methylation was directly correlated with tumor stage (pT3+pT4) (P = 0.001) and Gleason score (P = 0.018) in primary prostate carcinoma. CONCLUSIONS: Our results suggest that MCAM promoter hypermethylation deserves further attention as a potential diagnostic prostatic DNA marker in human prostate cancer.
|
Authors | Jun-Wei Liu, Jatin K Nagpal, Carmen Jeronimo, Ji Eun Lee, Rui Henrique, Myoung Sook Kim, Kimberly L Ostrow, Keishi Yamashita, Vim van Criekinge, Guojun Wu, Chu-So Moon, Barry Trink, David Sidransky |
Journal | The Prostate
(Prostate)
Vol. 68
Issue 4
Pg. 418-26
(Mar 01 2008)
ISSN: 0270-4137 [Print] United States |
PMID | 18196513
(Publication Type: Journal Article)
|
Copyright | Copyright 2008 Wiley-Liss, Inc. |
Chemical References |
- Biomarkers, Tumor
- CD146 Antigen
- MCAM protein, human
|
Topics |
- Adult
- Aged
- Base Sequence
- Biomarkers, Tumor
(genetics)
- CD146 Antigen
(genetics)
- Cell Line, Tumor
- DNA Methylation
- Gene Expression Regulation, Neoplastic
- Genetic Testing
- Humans
- Male
- Middle Aged
- Neoplasm Staging
(methods)
- Prostate
(pathology, physiology)
- Prostatic Neoplasms
(genetics, pathology)
|